Stocks
Baxter International (BAX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 85.5% | 73.5% | 71.9% | 89.1% | 96.4% | 95.3% | |||
| Changes by years, y/y, % | -11pp | -12pp | -2pp | +17pp | +7pp | +0.0% | |||
Baxter International. R&D/CAPEX, %
Baxter International. R&D/CAPEX, changes, pp
Baxter International (BAX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 95.3% | 105.8% | 95.4% | 90.5% | 90.9% | 95.3% | ||
| Changes by years, y/y, % | -12pp | +19pp | +5pp | +13pp | -4pp | |||
| Changes by quarters, q/q, % | +18pp | +10pp | -10pp | -5pp | +0pp | |||
